The present invention relates to biodegradable and bioerodible polyurethanes with a controlled degradation time and the use thereof in medicine, in particular as stent covers. The polyurethanes are composed of substantially hydrophobic block ABA poly(ester-ether) diols, hydrophilic polyoxyalkylene polymer, diisocyanate and a low-molecular polyol.